Cell and gene therapies (CGTs) represent a transformative frontier in modern medicine, offering potentially curative solutions for conditions like cancer, genetic disorders, and rare diseases. However, the logistical complexity of delivering these personalized therapies at scale requires advanced, high-performing systems that ensure reliability at every step.
For CGTs to reach their full potential and achieve global accessibility, scalable logistics systems are vital. This article delves into the challenges and innovative solutions shaping the scalability of CGT logistics.
Complete the form below to download the article.
